leisure time -WSS

leisure time

author：explore 2025-09-30 00:34:48 - browse：899

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： What does generative AI mean for health care? We asked experts
Next article： RSV shot was 90% effective at preventing hospitalizations in kids

focus

WSS

Ambulance rides for just $100? Advisers want major billing fixes

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

The Sacklers, horror, and ‘The Fall of the House of Usher’

The Sacklers, horror, and ‘The Fall of the House of Usher’

In his State of the Union, Biden takes clear aim at 'Big Pharma'

leisure time

leisure time

Sign up for Morning Rounds

explore

Apple is now the first public company to be valued at $3 trillion

Biotech incubator Curie.Bio graduates its first startup

What does generative AI mean for health care? We asked experts

Change Healthcare cyberattack prompts Medicare loan program

Sports medicine is finally prioritizing gender equality

STAT Executive Editor Rick Berke on STAT's 8th birthday

Heart attack and stroke risk calculators need revising

The problem with charging patients to message their doctors

Affirmative action in medical school literally saved lives

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

entertainment

Will General Catalyst be the first of many hospital takeovers?

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Precocious puberty in girls comes with mental health risks

FDA approves Recor Medical high blood pressure device

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

hotspot

focus

focus

entertainment